Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.

OBJECTIVES The magnitude of overdiagnosis of breast cancer associated with mammography screening remains controversial because of methodological issues. The objective of this study was to quantify overdiagnosis and overtreatment associated with a population-based screening programme, taking into account lead time and uncertainty concerning baseline incidence of breast cancers. MATERIAL AND METHODS A simulation model was developed to replicate incidence and detection rates of breast cancer observed in the Isère Département, France. The parameters of the model were estimated using an approximate Bayesian computation method. RESULTS For women aged 50-74 years during the 2007-2010 period, overdiagnosis of non-progressive breast cancers accounted for 17.0% (95% credibility interval (CI): 2.5%-35.5%) of all in situ cancers diagnosed, 5.5% (95% CI: 0.8%-9.8%) of all invasive cancers diagnosed, and 20.3% (95% CI: 3.0%-38.9%) of in situ and 13.0% (95% CI: 2.2%-23.3%) of invasive screen detected breast cancers. The estimates of overdiagnosis due to competitive causes of death were 1.0% (95% CI: 0.2%-%1.7) and 1.1% (95% CI: 0.6%-1.7%) for all in situ and invasive cancers diagnosed, respectively, and 1.3% (95% CI: 0.2%-2.0%) and 2.6% (95% CI: 1.4%-4.0%) of all in situ and invasive screen detected breast cancers, respectively. Among 1000 screen-detected cancers in 2010, 155 (95% CI: 27-284), 134 (95% CI: 10-242) and 140 (95% CI: 25-254) women underwent breast conserving surgery, lymph node dissection and radiation therapy for overdiagnosed cancers, respectively. CONCLUSION Our estimates of overdiagnosis should be balanced against the reduction of breast cancer mortality to assess the value of breast cancer screening programme.

[1]  Olivier François,et al.  Non-linear regression models for Approximate Bayesian Computation , 2008, Stat. Comput..

[2]  Katalin Csill'ery,et al.  abc: an R package for approximate Bayesian computation (ABC) , 2011, 1106.2793.

[3]  Eugenio Paci,et al.  Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review , 2012, Journal of medical screening.

[4]  Marc Colonna,et al.  Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data , 2011, BMJ : British Medical Journal.

[5]  H. Gilbert Welch,et al.  Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence , 2013 .

[6]  Russell P. Harris,et al.  Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods , 2015, BMJ : British Medical Journal.

[7]  D G Altman,et al.  The benefits and harms of breast cancer screening: an independent review , 2013, British Journal of Cancer.

[8]  Ralf Bender,et al.  Generating survival times to simulate Cox proportional hazards models , 2005, Statistics in medicine.

[9]  J. Groenewoud,et al.  Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  Nancy L Keating,et al.  A systematic assessment of benefits and risks to guide breast cancer screening decisions. , 2014, JAMA.

[11]  S. Duffy,et al.  Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening , 2005, Breast Cancer Research.

[12]  Balancing harms and benefits of service mammography screening programs: a cohort study , 2012, Breast Cancer Research.

[13]  P. Gøtzsche,et al.  Screening for breast cancer with mammography. , 2013, The Cochrane database of systematic reviews.

[14]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[15]  S. Duffy,et al.  Are breast cancer screening programmes increasing rates of mastectomy? Observational study , 2002, BMJ : British Medical Journal.

[16]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[17]  P. Gøtzsche,et al.  Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data , 2011, BMJ : British Medical Journal.

[18]  Welch Hg,et al.  Using Autopsy Series To Estimate the Disease “Reservoir” for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find? , 1997 .

[19]  Lurdes Y. T. Inoue,et al.  Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. , 2006, Journal of the National Cancer Institute. Monographs.

[20]  D. Balding,et al.  Approximate Bayesian computation in population genetics. , 2002, Genetics.

[21]  Bonnie N. Joe,et al.  The evolution of breast imaging: past to present. , 2014, Radiology.

[22]  S. Duffy,et al.  Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods. , 2015, Cancer epidemiology.

[23]  L. Irwig,et al.  Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. , 2007, The Lancet. Oncology.

[24]  S. Rosso,et al.  Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy , 2006, Breast Cancer Research.